KALRN and early-onset autosomal dominant Alzheimer disease: Genetic studies and analysis of post-mortem tissue have implicated Kalirin in cardiovascular disease, stroke, intellectual disability, schizophrenia, Huntington’s Disease and Alzheimer’s Disease along with substance abuse [16, 17, 19, 20, 61–69].